771 related articles for article (PubMed ID: 24667081)
1. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.
National Institutes of Health Consensus Development Panel
Pediatrics; 2001 Oct; 108(4):972-82. PubMed ID: 11581453
[TBL] [Abstract][Full Text] [Related]
3. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.
Muntau AC; Adams DJ; Bélanger-Quintana A; Bushueva TV; Cerone R; Chien YH; Chiesa A; Coşkun T; de Las Heras J; Feillet F; Katz R; Lagler F; Piazzon F; Rohr F; van Spronsen FJ; Vargas P; Wilcox G; Bhattacharya K
Mol Genet Metab; 2019 May; 127(1):1-11. PubMed ID: 31103398
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
[TBL] [Abstract][Full Text] [Related]
5. Phenylketonuria (PKU): screening and management.
NIH Consens Statement; 2000 Oct 16-18; 17(3):1-33. PubMed ID: 11757784
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
7. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.
Singh RH; Cunningham AC; Mofidi S; Douglas TD; Frazier DM; Hook DG; Jeffers L; McCune H; Moseley KD; Ogata B; Pendyal S; Skrabal J; Splett PL; Stembridge A; Wessel A; Rohr F
Mol Genet Metab; 2016 Jun; 118(2):72-83. PubMed ID: 27211276
[TBL] [Abstract][Full Text] [Related]
8. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the use of sapropterin in phenylketonuria.
Cunningham A; Bausell H; Brown M; Chapman M; DeFouw K; Ernst S; McClure J; McCune H; O'Steen D; Pender A; Skrabal J; Wessel A; Jurecki E; Shediac R; Prasad S; Gillis J; Cederbaum S
Mol Genet Metab; 2012 Jul; 106(3):269-76. PubMed ID: 22575621
[TBL] [Abstract][Full Text] [Related]
10. Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis.
Zimmermann M; Jacobs P; Fingerhut R; Torresani T; Thöny B; Blau N; Baumgartner MR; Rohrbach M
Mol Genet Metab; 2012 Jul; 106(3):264-8. PubMed ID: 22607939
[TBL] [Abstract][Full Text] [Related]
11. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
[TBL] [Abstract][Full Text] [Related]
12. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
[TBL] [Abstract][Full Text] [Related]
13. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry.
Grange DK; Hillman RE; Burton BK; Yano S; Vockley J; Fong CT; Hunt J; Mahoney JJ; Cohen-Pfeffer JL; ;
Mol Genet Metab; 2014 May; 112(1):9-16. PubMed ID: 24667082
[TBL] [Abstract][Full Text] [Related]
14. Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.
Zori R; Ahring K; Burton B; Pastores GM; Rutsch F; Jha A; Jurecki E; Rowell R; Harding C
Mol Genet Metab; 2019; 128(1-2):92-101. PubMed ID: 31439512
[TBL] [Abstract][Full Text] [Related]
15. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.
Blau N
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1207-18. PubMed ID: 23705856
[TBL] [Abstract][Full Text] [Related]
16. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
17. Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients.
Gordon P; Thomas JA; Suter R; Jurecki E
Mol Genet Metab; 2012 Apr; 105(4):672-6. PubMed ID: 22310224
[TBL] [Abstract][Full Text] [Related]
18. PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study.
Bratkovic D; Margvelashvili L; Tchan MC; Nisbet J; Smith N
Metabolism; 2022 Mar; 128():155116. PubMed ID: 34973284
[TBL] [Abstract][Full Text] [Related]
19. Phenylalanine hydroxylase deficiency: diagnosis and management guideline.
Vockley J; Andersson HC; Antshel KM; Braverman NE; Burton BK; Frazier DM; Mitchell J; Smith WE; Thompson BH; Berry SA;
Genet Med; 2014 Feb; 16(2):188-200. PubMed ID: 24385074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
